JP2013522369A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522369A5
JP2013522369A5 JP2013501398A JP2013501398A JP2013522369A5 JP 2013522369 A5 JP2013522369 A5 JP 2013522369A5 JP 2013501398 A JP2013501398 A JP 2013501398A JP 2013501398 A JP2013501398 A JP 2013501398A JP 2013522369 A5 JP2013522369 A5 JP 2013522369A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
compound
biological condition
formula
lack
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013501398A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013522369A (ja
JP5770261B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/029432 external-priority patent/WO2011119610A2/en
Publication of JP2013522369A publication Critical patent/JP2013522369A/ja
Publication of JP2013522369A5 publication Critical patent/JP2013522369A5/ja
Application granted granted Critical
Publication of JP5770261B2 publication Critical patent/JP5770261B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013501398A 2010-03-23 2011-03-22 （２０Ｓ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ジヒドロキシビタミンＤ３および（２０Ｒ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ヒドロキシビタミンＤ３ Expired - Fee Related JP5770261B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31663110P 2010-03-23 2010-03-23
US61/316,631 2010-03-23
PCT/US2011/029432 WO2011119610A2 (en) 2010-03-23 2011-03-22 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3

Publications (3)

Publication Number Publication Date
JP2013522369A JP2013522369A (ja) 2013-06-13
JP2013522369A5 true JP2013522369A5 (cg-RX-API-DMAC7.html) 2014-05-08
JP5770261B2 JP5770261B2 (ja) 2015-08-26

Family

ID=44170321

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501398A Expired - Fee Related JP5770261B2 (ja) 2010-03-23 2011-03-22 （２０Ｓ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ジヒドロキシビタミンＤ３および（２０Ｒ）−２−メチレン−１９−ノル−２２−ジメチル−１α，２５−ヒドロキシビタミンＤ３

Country Status (7)

Country Link
US (1) US8604009B2 (cg-RX-API-DMAC7.html)
EP (1) EP2556053B1 (cg-RX-API-DMAC7.html)
JP (1) JP5770261B2 (cg-RX-API-DMAC7.html)
AU (1) AU2011232633B2 (cg-RX-API-DMAC7.html)
CA (1) CA2794006C (cg-RX-API-DMAC7.html)
ES (1) ES2545403T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011119610A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8884039B2 (en) 2012-05-30 2014-11-11 Wisconsin Alumni Research Foundation Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
EP2866811A1 (en) 2012-06-29 2015-05-06 Wisconsin Alumni Research Foundation USE OF 2-METHYLENE-19-NOR-(20S)-1 alpha,25-DIHYDROXYVITAMIN D³ TO TREAT SECONDARY HYPERPARATHYROIDISM
US9539231B2 (en) 2014-01-17 2017-01-10 The Regents Of The University Of Colorado, A Body Corporate Method for treating triple-negative breast cancer using AMPI-109
US10369161B2 (en) 2014-12-30 2019-08-06 Wisconsin Alumni Research Foundation Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
US9539264B2 (en) 2014-12-30 2017-01-10 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
JPH0695892B2 (ja) 1990-01-12 1994-11-30 伊藤忠飼料株式会社 体脂肪の畜積量を減少させる飼料
US5086191A (en) * 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
DE69400495T2 (de) 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
JP3210156B2 (ja) 1993-10-18 2001-09-17 マツダ株式会社 自動車の前部車体構造
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6316642B1 (en) * 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US5843928A (en) 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6114317A (en) * 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
DK1180035T3 (da) 1999-04-01 2007-03-05 Univ Johns Hopkins Ikke kalcemiske, antiproliferative, transkriptionsmæssigt aktive svovlholdige analoger af 1-alpha, 25-dihydroxy-vitamin D3
PT1286962E (pt) * 2000-05-31 2008-07-30 Wisconsin Alumni Res Found Compostos de 2-etil- e 2-etilideno-19-nor-vitamina d
CA2416194C (en) * 2000-07-14 2009-10-06 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(s)-1.alpha.,25-dihydroxyvitamin d3 to increase bone strength
US6384087B1 (en) 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
AU2001275445B2 (en) * 2000-09-08 2006-07-27 Wisconsin Alumni Research Foundation 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6835723B2 (en) * 2001-12-13 2004-12-28 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
US6566352B1 (en) * 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
MXPA04008227A (es) * 2002-03-29 2005-08-19 Wisconsin Alumni Res Found Metodo para sintetizar 1?-hidroxi-2-metilen-19-nor-homopregnacalciferol.
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
US20080249068A1 (en) 2002-09-05 2008-10-09 Deluca Hector F Method of Extending the Dose Range of Vitamin D Compounds
US6894037B2 (en) * 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
CA2535185C (en) * 2003-08-20 2013-04-23 Wisconsin Alumni Research Foundation 2-methylene-19-nor-vitamin d2 compounds
WO2005027929A1 (en) 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen
JP2007505881A (ja) * 2003-09-19 2007-03-15 ファイザー・プロダクツ・インク ２−アルキリデン−１９−ノル−ビタミンｄ誘導体およびエストロゲンアゴニスト／アンタゴニストの組合せを含む医薬組成物および方法
WO2005027931A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
AU2004273660B2 (en) * 2003-09-19 2010-08-19 Wisconsin Alumni Research Foundation (Warf) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
US7214670B2 (en) * 2003-09-24 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
US7053075B2 (en) * 2003-11-25 2006-05-30 Deluca Hector F Methods for reducing body fat using vitamin D compounds
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
WO2005079464A2 (en) * 2004-02-17 2005-09-01 Wisconsin Alumni Research Foundation Vitamin d receptor antagonists and their use in treating asthma
US7214671B2 (en) * 2004-02-19 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
US7713951B2 (en) * 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
MX2007006546A (es) * 2004-11-22 2007-08-17 Wisconsin Alumni Res Found Analogos de 17,20(e)-deshidro vitamina d y sus usos.
US7244719B2 (en) * 2004-11-22 2007-07-17 Wisconsin Alumni Research Foundation 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
EP1828115A4 (en) * 2004-11-22 2010-05-05 Wisconsin Alumni Res Found 2-METHYLENE-19-NOR (20S) -1ALPHA-HYDROXYTRISHOMOPREGNACALCIFEROL
NZ555280A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2-methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses
WO2006057884A2 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES
NZ555283A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
NZ561076A (en) * 2005-02-11 2010-01-29 Wisconsin Alumni Res Found 2-methylene-19-nor-(20S-24EPI)-1alpha,25-dihydroxyvitamin-D2
ES2404061T3 (es) * 2005-02-11 2013-05-23 Wisconsin Alumni Research Foundation 2-Metileno-19-nor-(20S-24S)-1-alfa,25-dihidroxivitamina-D2
AU2006230296B2 (en) * 2005-03-29 2011-07-07 Wisconsin Alumni Research Foundation 2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
WO2006119309A2 (en) 2005-05-03 2006-11-09 Wisconsin Alumni Research Foundation 19,26,27-TRINOR-1α,25-DIHYDROXYVITAMIN D3 COMPOUNDS
WO2008035207A2 (en) * 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
NZ571773A (en) * 2006-04-06 2011-11-25 Wisconsin Alumni Res Found 2-Methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof
MX2008012912A (es) * 2006-04-06 2008-11-26 Wisconsin Alumni Res Found Analogos de 2-metilen-1a,25-dihidroxi-19,21-dinorvitamina d3 y sus usos.
US7741314B2 (en) * 2006-09-28 2010-06-22 Wisconsin Alumni Research Foundation 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
US7718638B2 (en) * 2007-12-28 2010-05-18 Wisconsin Alumni Research Foundation (20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs
WO2009086438A2 (en) * 2007-12-28 2009-07-09 Wisconsin Alumni Research Foundation 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs
CA2710954C (en) * 2007-12-28 2015-07-21 Wisconsin Alumni Research Foundation (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
JP2011513428A (ja) * 2008-03-06 2011-04-28 ウイスコンシン アラムナイ リサーチ ファウンデーシヨン １９−ノル含有ビタミンｄ化合物の局所投与によって表皮の厚さを増す方法
JP5753386B2 (ja) * 2008-03-10 2015-07-22 ウイスコンシン アラムナイ リサーチ ファウンデーシヨンＷｉｓｃｏｎｓｉｎ Ａｌｕｍｎｉ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ ビタミンｄ化合物及びそれを含有する高眼圧症治療剤
US8399439B2 (en) * 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US7893043B2 (en) * 2008-07-10 2011-02-22 Wisconsin Alumni Research Foundation 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
US7888339B2 (en) * 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
WO2011017165A1 (en) * 2009-08-03 2011-02-10 Wisconsin Alumni Research Foundation Method of preventing renal disease and treating symptoms thereof
AU2010300528B2 (en) * 2009-10-02 2016-02-11 Wisconsin Alumni Research Foundation (20S,22E)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin D3 analogs

Similar Documents

Publication Publication Date Title
JP2009525981A5 (cg-RX-API-DMAC7.html)
JP2010505739A5 (cg-RX-API-DMAC7.html)
JP2009532458A5 (cg-RX-API-DMAC7.html)
EP2854796B1 (en) Combinations of a vascular disrupting agent and a hypoxia-targeting agent for use in the treatment of cancer
JP2013522369A5 (cg-RX-API-DMAC7.html)
JP2009536191A5 (cg-RX-API-DMAC7.html)
JP2007502832A5 (cg-RX-API-DMAC7.html)
RU2014108885A (ru) Ингибирование транзиторного рецепторного потенциала ионного канала trpa1
EP2902025A1 (en) Therapeutic agent for dyslipidemia
JP2010540555A5 (cg-RX-API-DMAC7.html)
JP2008520703A5 (cg-RX-API-DMAC7.html)
JP2007504168A5 (cg-RX-API-DMAC7.html)
JPWO2014157444A1 (ja) 低用量イリノテカン塩酸塩水和物を含有する抗腫瘍剤
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
CA2597624A1 (en) 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
JP2008520705A5 (cg-RX-API-DMAC7.html)
JP2008520691A5 (cg-RX-API-DMAC7.html)
JP2009502777A5 (cg-RX-API-DMAC7.html)
JP2011527695A5 (cg-RX-API-DMAC7.html)
JP2019167351A (ja) 癌治療
JP2013522370A5 (cg-RX-API-DMAC7.html)
JP2008520690A5 (cg-RX-API-DMAC7.html)
JP2006523239A5 (cg-RX-API-DMAC7.html)
JP2011527699A5 (cg-RX-API-DMAC7.html)
JP2014520101A5 (cg-RX-API-DMAC7.html)